AVCT Avacta Group Plc

0.7967USD60.50 GBp · LSE+6.51%Mkt Cap: 348.66M USDP/E: —

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. The company's lead product candidate is AVA6000, a peptide drug co…

Institutional holders1 on file

Key Statistics

Company
Market Cap348.66M USD
Enterprise Value350.03M USD
Revenue (TTM)148.80K USD
Gross Profit148.80K USD
Net Income (TTM)-50.85M USD
Revenue/Share0.00 USD
Last Price0.7967 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees81
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BYYW9G87
Valuation
P/E (Trailing)—
P/E (Forward)-22.83
PEG—
EV/EBITDA-8.89
EV/Revenue2352.32
P/S2343.08
P/B75.62
EPS (TTM)-0.12 USD
EPS (Forward)-0.03 USD
52W Range
0.000066% of range1.211
52W High1.211 USD
52W Low0.0000 USD
Profitability
Gross Margin100.00%
Oper. Margin-26569.03%
EBITDA Margin0.00%
Profit Margin-34169.91%
ROE-1559.45%
ROA-131.26%
ROIC-5472.12%
ROCE-903.07%
Growth
Revenue Growth0.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.27M USD
CapEx (TTM)69.79K USD
FCF Margin-15198.45%
FCF Yield-6.49%
Net Debt-538.59K USD
Net Debt/EBITDA0.01
Net Debt/FCF—
Balance Sheet
Debt/Equity6.02
Current Ratio0.95
Quick Ratio0.95
Book Value/Sh0.01 USD
Cash/Share0.06 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJan 26, 2016
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.192 USD
Upside (mean)+49.6%
Target Range0.7243 USD – 1.541 USD
0.7243+49.6% to mean1.541
# Analysts4
Ownership
Shares Out.437.63M
Float440.93M
Insiders3.16%
Institutions3.11%
Technical
SMA 500.8759 (-9.0%)
SMA 2000.9111 (-12.6%)
Beta-0.15
S&P 52W Chg12.08%
Avg Vol (30d)2.11M
Avg Vol (10d)3.28M
Technical Indicators
RSI (14)50.1
MACD-1.9436
MACD Signal-2.5115
MACD Hist.+0.5679
BB Upper0.8504 USD
BB Middle0.7720 USD
BB Lower0.6936 USD
BB Width20.30%
ATR (14)0.0465 USD
Vol Ratio (20d)0.91x

About Avacta Group (LON: AVCT)

›

Avacta Group (LON: AVCT) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 81 employees.

The shares were at 60.50 GBp on 19 November 2026, down 16.0% over 52 weeks.

Its market capitalisation is 264.77M GBP.

Avacta Group reports flat revenue year over year.

It holds more cash than debt, a net cash position of 409.00K GBP. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 90.50 GBp is 49.6% above the current price.